Quantum-Si Incorporated (QSI)
|Net Income (ttm)||n/a|
|Trading Day||June 15|
|Day's Range||8.50 - 8.84|
|52-Week Range||8.35 - 25.00|
Quantum-Si, Revolutionizing Proteomics, Closes Business Combination and Will Begin Trading Under the Ticker “QSI” on ...
GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSi” or “the Company”), a company pioneering next-generation semiconductor chip-based proteomics, today...
HighCape Capital Acquisition Corp. Reminds Stockholders to Vote in Favor of the Business Combination with Quantum-Si ...
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- HighCape Capital Acquisition Corp. (Nasdaq: CAPA) (“HighCape”), a special purpose acquisition company sponsored by leading healthcare growth equity investment...
Quantum-Si and HighCape Capital Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Busin...
Special meeting of HighCape stockholders scheduled for June 9, 2021 Special meeting of HighCape stockholders scheduled for June 9, 2021
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Marijn Dekkers, Ph.D. and Ruth Fat...
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Michael Mina, M.D., Ph.D., Assista...
Ark Funds hosted an investor webinar Tuesday, sharing ideas on several industries and portfolio components, including a discussion on some names in the genomics space. Ark Funds On Genomics: Ark Funds i...
HighCape Capital (CAPA) stock is soaring higher on Thursday with heavy trading after announcing plans for a SPAC merger with Quantum-Si. The post CAPA Stock: 16 Things for to Know About HighCape Capital...
Inventor Dr. Rothberg on Quantum-SI SPAC deal
CNBC's "Squawk on the Street" team discusses SPACs as Highcape Capital surges on its $1.46 billion deal with Quantum-SI, a high-speed, next-gen DNA sequencing company, with inventor Dr. Jonathan Rothberg.
HighCape Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
|Stock Exchange |
|Ticker Symbol |